Viewing StudyNCT04634435

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 3:27 PM
Last Modification Date: 2024-10-26 @ 1:49 PM
Study NCT ID: NCT04634435
Status: RECRUITING
Last Update Posted: 2023-08-29
First Post: 2020-10-21
Brief Title: Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients
Sponsor: Biohaven Pharmaceuticals Inc
Organization: Biohaven Pharmaceuticals Inc
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Multiple Myeloma
Keywords:
Name View
hematological malignancies View
Cell Therapy View
CIML NK cell therapy View
cytokine induced memory-like natural killer cell therapy View
immunotherapy View
antibody-dependent cell-mediated cytotoxicity View
ADCC View
CD38 positive View
CD38 View
plasma cells View
multiple myeloma View